-+ 0.00%
-+ 0.00%
-+ 0.00%

Kasvu Therapeutics raises €30 million in Series A led by Hadean Ventures, with Nordic Science Investments participating

PUBT·09/24/2026 08:18:43
Listen to the news
Kasvu Therapeutics raises €30 million in Series A led by Hadean Ventures, with Nordic Science Investments participating
  • Kasvu Therapeutics raised EUR 30 million in a Series A led by Hadean Ventures, with Nordic Science Investments participating.
  • Funding supports Phase 1/1b development of small-molecule neuroplastogens for depression and other neuropsychiatric or neurodegenerative disorders.
  • Kasvu targets TrkB and BDNF signaling to boost neuroplasticity, aiming to separate antidepressant benefits from psychedelic hallucinations.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nordic Science Investments published the original content used to generate this news brief on September 24, 2026, and is solely responsible for the information contained therein.